SEC Form 4 · accession 0000899243-16-022513
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony Wondka
Officer — See Remarks
Period of report
Jun 8, 2016
Accepted (ET)
Jun 10, 2016 · 7:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $1.20 | Jun 8, 2016 | A | 46,863 | A | — | Jun 8, 2026 | Common Stock | 46,863 | 46,863 | D |
Explanation of responses
- F1The vesting schedule for the option is as follows: twenty-five percent (25%) of the shares subject to the option shall vest immediately, and thereafter one forty-eighth (1/48th) of the remaining shares shall vest each month over the next forty-eight (48) months.
Remarks
Senior Vice President, Research and Development